Home › NDC Lookup › RxCUI directory › RxCUI 2387328

28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolat... — RxCUI 2387328

RxNorm drug concept · Semantic branded drug
RxCUI 2387328 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2387328
Official name28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBREZTRI (budesonide 160 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT / glycopyrrolate 9 MCG/ACTUAT) Metered Dose Inhaler, 28 ACTUAT; BREZTRI 160/9/4.8 MCG INHAL Metered Dose Inhaler, 28 Actuations
FDA products mapped2
Package NDCs mapped6
Reported Medicaid activity (SDUD)156,033 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Budesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You might notice some improvement on the very first day, but don't give up if you don't feel a big difference right away. The full benefit from this spray usually builds up over ab...
  • How long does it take for budesonide nasal spray to actually work?
  • Children 6 and older can use budesonide nasal spray, but an adult should supervise use for kids ages 6 to under 12. The spray should not be used in children under 6. One thing to k...
  • Can my child use this spray, and is it safe for long-term use in kids?
📖 Read our full Budesonide Nasal Spray guide →

🕸️ Concept Web — How 28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 28 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri] RxCUI 2387328

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Budesonide 19831
    • Formoterol 25255
    • Glycopyrronium 1546438
    • Budesonide / formoterol / glycopyrronium 2387330
    • Formoterol fumarate 236216
    • Glycopyrrolate 4955
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Breztri 2387325
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Budesonide / formoterol / glycopyrronium Metered Dose Inhaler 2386036
    • Budesonide / formoterol fumarate / glycopyrrolate Metered Dose Inhaler 2645669
    • Budesonide / formoterol / glycopyrronium Inhalant Product 2386035
    • Budesonide / formoterol fumarate / glycopyrrolate Inhalant Product 2662629
    • Budesonide / formoterol / glycopyrronium Metered Dose Inhaler [Breztri] 2387323
    • Budesonide / formoterol fumarate / glycopyrrolate Metered Dose Inhaler [Breztri] 2658007
    • Breztri Inhalant Product 2387324
    • Metered Dose Inhaler 721654
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 20 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT [Breztri] SBDC · 2387327
  • Budesonide / formoterol / glycopyrronium Metered Dose Inhaler [Breztri] SBDF · 2387323
  • Budesonide / formoterol fumarate / glycopyrrolate Metered Dose Inhaler [Breztri] SBDFP · 2658007
  • Breztri Inhalant Product SBDG · 2387324
  • Breztri BN · 2387325

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 2387328 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00310-4616-12 120 AEROSOL, METERED in 1 INHALER (0310-4616-12) BREZTRI AstraZeneca Pharmaceuticals LP 2020-07-23
00310-4616-28 28 AEROSOL, METERED in 1 INHALER (0310-4616-28) BREZTRI AstraZeneca Pharmaceuticals LP 2020-07-23
00310-4616-39 28 AEROSOL, METERED in 1 INHALER (0310-4616-39) BREZTRI AstraZeneca Pharmaceuticals LP 2020-07-23
00310-6616-01 120 AEROSOL, METERED in 1 INHALER (0310-6616-01) BREZTRI AstraZeneca Pharmaceuticals LP 2026-04-27
00310-6616-39 28 AEROSOL, METERED in 1 INHALER (0310-6616-39) BREZTRI AstraZeneca Pharmaceuticals LP 2026-04-27
00310-6616-95 28 AEROSOL, METERED in 1 INHALER (0310-6616-95) BREZTRI AstraZeneca Pharmaceuticals LP 2026-04-27
Observed labelers: AstraZeneca Pharmaceuticals LP (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.